seed
Stage
About
PanTarg is a Danish biotechnology company developing antibody-drug conjugates (ADCs) with pan-cancer potential, focusing on pancreatic cancer and other hard-to-treat solid tumors by targeting both cancer cells and tumor stroma.
Explore PanTarg's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.